chalcone has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 4 (57.14) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, XX; Liang, G; Mei, YN; Shen, Z; Xing, SH; Yang, HM; Zheng, XH; Zhu, JF | 1 |
| Mustofa, M; Padauleng, N; Purnomosari, D; Wahyuningsih, TD | 1 |
| Al Moustafa, AE; Alali, F; Cyprian, FS; El Sayed, K; Elkhalifa, D; Khalil, A; Qusa, M; Siddique, AB | 1 |
| Chen, S; Huang, J; Huang, Q; Li, Y; Luo, Y; Wang, C; Wu, W; Yu, L; Zha, D; Zhang, C; Zhang, J; Zhou, W | 1 |
| Oh, YJ; Seo, YH | 1 |
| Birk, AM; Going, CC; Kumar, V; Malhotra, S; Pandrala, M; Pitteri, SJ; Rice, MA; Stoyanova, T; Tailor, D | 1 |
| Fujimori, M; Fujita, T; Inoue, K; Mizukami, T; Okawara, T | 1 |
7 other study(ies) available for chalcone and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
A chalcone-syringaldehyde hybrid inhibits triple-negative breast cancer cell proliferation and migration by inhibiting CKAP2-mediated FAK and STAT3 phosphorylation.
Topics: Apoptosis; Benzaldehydes; Cell Line, Tumor; Cell Movement; Cell Proliferation; Chalcone; Chalcones; Cytoskeletal Proteins; Cytoskeleton; Focal Adhesion Kinase 1; Focal Adhesion Protein-Tyrosine Kinases; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Recurrence, Local; Phosphorylation; STAT3 Transcription Factor; Triple Negative Breast Neoplasms | 2022 |
Chalcone-3 Inhibits the Proliferation of Human Breast Cancer MDA-MB-231 Cell Line.
Topics: Cell Division; Chalcone; Chalcones; ErbB Receptors; Humans; MDA-MB-231 Cells; Triple Negative Breast Neoplasms | 2023 |
Design, synthesis, and validation of novel nitrogen-based chalcone analogs against triple negative breast cancer.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Proliferation; Cell Survival; Chalcone; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Female; Humans; Mammary Neoplasms, Experimental; Mice; Mice, Nude; Models, Molecular; Molecular Structure; Nitrogen; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Tumor Cells, Cultured | 2020 |
Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chalcone; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Pyrazines; Structure-Activity Relationship; Triple Negative Breast Neoplasms | 2021 |
A novel chalcone-based molecule, BDP inhibits MDA‑MB‑231 triple-negative breast cancer cell growth by suppressing Hsp90 function.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chalcone; Chalcones; Female; Gene Expression Regulation, Neoplastic; HSP90 Heat-Shock Proteins; Humans; Matrix Metalloproteinase 9; Mice; Neoplasm Proteins; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Triple Negative Breast Neoplasms; Xenograft Model Antitumor Assays | 2017 |
Quantitative Proteomic Profiling Reveals Key Pathways in the Anticancer Action of Methoxychalcone Derivatives in Triple Negative Breast Cancer.
Topics: Antineoplastic Agents; Apoptosis; Cell Line; Cell Line, Tumor; Cell Proliferation; Chalcone; Female; G1 Phase Cell Cycle Checkpoints; Humans; Metabolic Networks and Pathways; Proteomics; Triple Negative Breast Neoplasms | 2018 |
Identification of a novel inhibitor of triple-negative breast cancer cell growth by screening of a small-molecule library.
Topics: Antineoplastic Agents; Benzofurans; Benzylidene Compounds; Cell Line, Tumor; Cell Proliferation; Chalcone; Drug Screening Assays, Antitumor; Female; Gene Expression Regulation, Neoplastic; Gene Ontology; Humans; Molecular Targeted Therapy; Signal Transduction; Small Molecule Libraries; Triple Negative Breast Neoplasms | 2014 |